WGS Logo

GeneDx Holdings Corp. (WGS) 

NASDAQ
Market Cap
$2.13B
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
55 of 960
Rank in Industry
3 of 43

Largest Insider Buys in Sector

WGS Stock Price History Chart

WGS Stock Performance

About GeneDx Holdings Corp.

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in …

Insider Activity of GeneDx Holdings Corp.

Over the last 12 months, insiders at GeneDx Holdings Corp. have bought $8.55M and sold $116.22M worth of GeneDx Holdings Corp. stock.

On average, over the past 5 years, insiders at GeneDx Holdings Corp. have bought $57.01M and sold $30.5M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Casdin Capital, LLC () — $34.19M.

The last purchase of 30,000 shares for transaction amount of $675,477 was made by Casdin Capital, LLC () on 2024‑06‑04.

List of Insider Buy and Sell Transactions, GeneDx Holdings Corp.

2024-12-16SaleChief Executive Officer
10,501
0.0371%
$76.75$805,995-2.73%
2024-12-16SaleCHIEF FINANCIAL OFFICER
3,728
0.0132%
$76.75$286,139-2.73%
2024-12-09SaleChief Executive Officer
3,661
0.0139%
$76.37$279,598+3.53%
2024-12-09SaleCHIEF FINANCIAL OFFICER
1,137
0.0043%
$76.37$86,836+3.53%
2024-12-02SaleCHIEF FINANCIAL OFFICER
263
0.001%
$78.39$20,617-1.20%
2024-11-22SaleCHIEF FINANCIAL OFFICER
9,981
0.0353%
$76.07$759,242-1.66%
2024-11-21SaleCHIEF FINANCIAL OFFICER
12,019
0.0412%
$73.76$886,568+8.08%
2024-11-20Saledirector
15,490
0.0497%
$69.13$1.07M+11.56%
2024-11-19Saledirector
31,510
0.1043%
$71.28$2.25M+8.84%
2024-11-18Sale10 percent owner
126,782
0.4167%
$70.78$8.97M+8.64%
2024-11-18SaleChief Executive Officer
22,307
0.0729%
$70.34$1.57M+8.64%
2024-11-15Sale10 percent owner
20,359
0.066%
$69.78$1.42M+12.85%
2024-11-15SaleChief Executive Officer
23,108
0.0756%
$70.48$1.63M+12.85%
2024-10-31Sale10 percent owner
865,800
3.0153%
$75.00$64.94M-7.03%
2024-10-29SaleChief Executive Officer
2,154
0.0067%
$66.60$143,456-8.45%
2024-10-29SaleCHIEF FINANCIAL OFFICER
274
0.0008%
$66.60$18,248-8.45%
2024-09-16SaleChief Executive Officer
10,501
0.0183%
$37.59$394,733+88.41%
2024-09-16SaleCHIEF FINANCIAL OFFICER
2,635
0.0046%
$37.59$99,050+88.41%
2024-09-09SaleChief Executive Officer
3,639
0.0056%
$33.33$121,288+102.88%
2024-09-09SaleCHIEF FINANCIAL OFFICER
895
0.0014%
$33.33$29,830+102.88%

Insider Historical Profitability

213.21%
Casdin Capital, LLC
3093509
11.2608%
$77.4090
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI10 percent owner
2719692
9.9001%
$77.4013<0.0001%
OPKO HEALTH, INC.10 percent owner
2646972
9.6354%
$77.40119<0.0001%
Stueland KatherineChief Executive Officer
71146
0.259%
$77.40121<0.0001%
Ryan Jasondirector
0
0%
$77.4025+1256.88%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.